Odyssey Therapeutics Inc (ODTX)

Aug 16, 2026

Top Odyssey Therapeutics (ODTX) Competitors 2026 - MarketBeat

Aug 16, 2026

Aug 13, 2026

Odyssey Therapeutics (ODTX) Stock Trends and Sentiment 2026 - marketbeat.com

Aug 13, 2026

Aug 11, 2026

J.P. Morgan Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Raises Target Price to $29 - Moomoo

Aug 11, 2026

Aug 10, 2026

Odyssey Therapeutics (ODTX) Looks Fully Valued As Earnings And Evotec Deal Refocus Attention - Yahoo Finance

Aug 10, 2026

Aug 10, 2026

Odyssey Therapeutics (ODTX) Stock Looks Reasonable As AI Research News Lands - Sahm

Aug 10, 2026

Aug 09, 2026

Odyssey Therapeutics Ord Shs (Proposed) (ODTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 09, 2026

Aug 08, 2026

Odyssey Therapeutics Hits $900M Valuation In Nasdaq Debut, Stock Climbs 13% Before Diving Lower - Stocktwits

Aug 08, 2026

Aug 07, 2026

Evotec and Odyssey Forge AI-Powered Drug Discovery Pact Targeting Autoimmune Diseases - finance.biggo.com

Aug 07, 2026

Aug 07, 2026

Odyssey Therapeutics (NASDAQ:ODTX) Given New $29.00 Price Target at JPMorgan Chase & Co. - MarketBeat

Aug 07, 2026

Aug 07, 2026

ODTX Price Today: Odyssey Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - mexc.co

Aug 07, 2026

Aug 06, 2026

EQS-News: Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases - sharewise.com

Aug 06, 2026

Aug 06, 2026

Odyssey Therapeutics: Q2 Earnings Snapshot - marketscreener.com

Aug 06, 2026

Aug 06, 2026

Odyssey Therapeutics, Inc. Q2 2026: Revenue $0 EPS $(1.74) — 10-Q Summary - TradingView

Aug 06, 2026

Aug 06, 2026

Biotech Stocks At 52-Week HighsBVS, TVTX, ODTX, CRL Climb With Q2 Results, ACRS - RTTNews

Aug 06, 2026

Aug 06, 2026

Evotec and Odyssey Pair AI With Lab Tests for Immune Diseases - Stock Titan

Aug 06, 2026

Aug 06, 2026

Evotec Se and Odyssey Therapeutics, Inc. Enter Ai-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases - marketscreener.com

Aug 06, 2026

Aug 06, 2026

Evotec signs AI drug discovery partnership with Odyssey - grafa.com

Aug 06, 2026

Aug 06, 2026

Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases - Yahoo Finance

Aug 06, 2026

Aug 06, 2026

Evotec : and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases - marketscreener.com

Aug 06, 2026

Aug 05, 2026

Odyssey Therapeutics (ODTX) Earnings Date and Reports 2026 - MarketBeat

Aug 05, 2026

Aug 04, 2026

Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times

Aug 04, 2026

Aug 04, 2026

Odyssey Therapeutics reports Q2 2026 net loss $52.8M; cash $433.1M to fund into 2H 2028 - TradingView

Aug 04, 2026

Jul 27, 2026

Odyssey Therapeutics, Inc. Revenue Breakdown – NASDAQ:ODTX - TradingView

Jul 27, 2026

Jul 25, 2026

ODTX|Odyssey Therapeutics Ord Shs (Proposed)|Price:18.660|Chg%:+0.990 - TradingKey

Jul 25, 2026

Jul 09, 2026

Enterprise value to revenue forward of Odyssey Therapeutics, Inc. – NASDAQ:ODTX - TradingView

Jul 09, 2026

Jul 09, 2026

Price to book forward of Odyssey Therapeutics, Inc. – NASDAQ:ODTX - TradingView

Jul 09, 2026

Jul 09, 2026

Price to earnings forward of Odyssey Therapeutics, Inc. – NASDAQ:ODTX - TradingView

Jul 09, 2026

Jul 09, 2026

Price to sales forward of Odyssey Therapeutics, Inc. – NASDAQ:ODTX - TradingView

Jul 09, 2026

Jul 05, 2026

Odyssey Therapeutics prices upsized IPO at $18 per share - Investing.com

Jul 05, 2026

Jul 03, 2026

Odyssey Therapeutics Inc (ODTX) Dividend News Alerts - DividendInvestor.com

Jul 03, 2026

Jun 26, 2026

Enterprise value to EBIT forward of Odyssey Therapeutics, Inc. – NASDAQ:ODTX - TradingView

Jun 26, 2026

Jun 23, 2026

Form 8K ODYSSEY THERAPEUTICS For: 23 June By Investing.com - Investing.com Nigeria

Jun 23, 2026

Jun 23, 2026

Odyssey posts June 2026 corporate presentation highlighting OD-001 Phase 2a results and $464M pro forma cash - TradingView

Jun 23, 2026

Jun 23, 2026

Odyssey Therapeutics (NASDAQ: ODTX) details I&I pipeline, OD-001 data and cash - Stock Titan

Jun 23, 2026

Jun 22, 2026

ODTX Stock Price and Chart — NASDAQ:ODTX - TradingView

Jun 22, 2026

Jun 21, 2026

Odyssey Therapeutics, Inc.(NasdaqCM: ODTX) added to S&P TMI Index - marketscreener.com

Jun 21, 2026

Jun 20, 2026

Odyssey Therapeutics, Inc. (ODTX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex

Jun 20, 2026

Jun 19, 2026

Analysts Offer Insights on Healthcare Companies: Odyssey Therapeutics, Inc. (ODTX), Capricor Therapeutics (CAPR) and Medtronic (MDT) - The Globe and Mail

Jun 19, 2026

Jun 19, 2026

IPO Tracker 2026: Cardio biotech Kardigan binds off $400M upsized IPO - BioSpace

Jun 19, 2026

Jun 18, 2026

TD Cowen Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating - Moomoo

Jun 18, 2026

Jun 18, 2026

ODTX Reiterated by Oppenheimer -- Price Target Maintained at $40 - GuruFocus

Jun 18, 2026